16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease...

33
•16-18 million infected •100 million at risk •50,000 deaths annually •leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative agent of Chagas disease discovered by Carlos Chagas named organism after mentor, Oswaldo Cruz determined life cycle described salient features of disease

Upload: christian-mccann

Post on 27-Mar-2015

218 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative

• 16-18 million infected• 100 million at risk• 50,000 deaths annually• leading cause of cardiac disease

in S. and Central America

Trypanosoma cruzi• causative agent of Chagas

disease• discovered by Carlos Chagas

• named organism after mentor, Oswaldo Cruz

• determined life cycle• described salient features

of disease

Page 2: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative

Genera

• Triatoma• Rhodnius• Panstrongylus

Common Names

• triatomine bugs• reduviid bugs• assassin bugs• kissing bugs• conenose bugs

Page 3: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative

Triatomine Vectors

• >100 species can transmit• 3 primary vectors

• T. dimidiata (central Am.)• R. prolixis (Colombia and

Venezuela)• T. infestans (‘southern cone’

countries)

Page 4: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative

•metacyclic trypomastigotes excreted in triatomine feces

•entry via bite wound, mucous membranes (eg., eyes), hair follicles

Page 5: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative

•metacyclic trypomastigotes excreted in triatomine feces

•entry via bite wound, mucous membranes (eg., eyes), hair follicles

•blood-stream trypomastigotes are non-dividing

•trypomastigotes invade host cells and convert to amastigotes

Page 6: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative

• amastigotes replicate by binary fission

Page 7: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative
Page 8: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative

• amastigotes transform to trypomastigotes

• release of trypomastigotes and reinvasion of host cells

• ingestion of blood-stream trypomastigotes by triatomine

Page 9: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative

•conversion to epimastigotes and replication in midgut

•migration to hindgut and transformation to trypomastigote

Page 10: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative

SOURCE COMMENTS

VectorNatural transmission by triatomine bugsthrough contamination with infected feces.

TransfusionA prevalent mode of transmission in urbanareas. Gentian violet treatment (24 hr)eliminates parasites in blood.

CongenitalOccurs during any stage of T. cruziinfection. Can result in premature labor,abortion neonatal death.

AccidentalIngestion of food contaminated withmetacyclic trypomastigotes. Laboratoryaccidents.

Modes of Transmission

Page 11: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative

Types of Vector Transmission Salivarian Stercorarian

transmission via mouth parts

very efficient

infection rate in vector is low

hind gut station

acquired from feces or eating vector

inefficient

infection rate in vector is high

Page 12: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative

• ‘early’ defecation (i.e., during triatomine feeding)

• colonization of human habitats adobe walls thatched roofs

• para-domiciliary cycles animal stalls adjacent to

domicile• proximity to sylvatic cycle

Factors Influencing Human Transmission

Page 13: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative
Page 14: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative
Page 15: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative
Page 16: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative
Page 17: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative

• triatomine bugs found in U.S.• parasite common in wild animals• 5 confirmed autochthonous cases

• why no autochthonous transmission?• late defecaters• zoophillic vectors• better houses

Trypanosoma cruzi in the U.S.

inefficient transmission +

limited vector-human contact

Page 18: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative

• improvement of human dwellings • separation of animal stalls from house• health education• insecticides

• synthetic pyrethroids• eg., Southern Cone Initiative

• major in Chagas (T. infestans)• little affect with R. prolixis

• gentian violet in blood for transfusions

Chagas Control

Page 19: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative

Clinical Course of Chagas• Acute Phase

active infection 1-4 months duration most are asymptomatic (children

most likely to be symptomatic)• Indeterminate Phase

10-30 years of latency relatively asymptomatic with no

detectable parasitemia seropositive

• Chronic Phase 10-30% of infected exhibit cardio-

myopathy or megasyndromes

Page 20: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative

Acute Phase Features

• 1-2 week incubation period• local inflammation

• Romaña’s sign• chagoma

• symptoms can include: fever, malaise, lymphadenopathy, hepatosplenomegaly, nausea, diarrhea

• acute, often fatal, myocarditis develops in a few individuals• high parasitemias in

myofibrils

Page 21: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative

• long latency characterized by seropositivity and no parasitemia

• higher prevalence of ECG abnormalities in asymptomatic seropositive persons

• progressive development of abnormalities• right bundle branch block• left anterior hemiblock

• clinical presentations include:• arrhythmias and conduction defects• congestive heart failure• thromboembolic phenomenon

Chronic Chagas' Cardiomyopathy

Page 22: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative

• cardiomegaly• hypertrophy*• apical aneurysm

(left ventricle)• extensive fibrosis* cellular

infiltration

*correlates best with cardiac symptoms

Pathology

Page 23: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative

• cardiomegaly• hypertrophy*• apical aneurysm

(left ventricle)• extensive fibrosis* cellular

infiltration

*correlates best with cardiac symptoms

Pathology

Page 24: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative

• prevalence varies by geographical zones• Chili, central Brazil

• colon and esophagus most frequently affected

• megaesophagus• painful swallowing• regurgitation

• megacolon• severe constipation

Megaviscerae

Page 25: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative
Page 26: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative

• destruction of parasympathetic neurons dilation

non-Chagas

Chagas

C = heartS = colonE = esophagus

Page 27: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative

Basis of Pathogenesis

autoimmunity?parasite-mediated

destruction? few (if any) parasites anti-self responses

(humoral and cellular) slow development organ specificity

persistent low levelparasitemia (PCR)

inflammation correlateswith parasites

disease exacerbated byimmune suppression

successful treatment ofchronic patients (?)

• altered immune response? (Th1Th2 switch correlated with severe disease)

• chagasic factor or toxin? (proposed by not found)

Page 28: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative

• history of living in infested house

• bug bite, chagoma, Romaña's sign

• cardiac or gastro-intestinal symptoms• imaging

• detection of parasite (acute stage)

• serology (chronic stage)

DIAGNOSIS

Page 29: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative

• parasite detection• direct examination• stained blood smears• inoculation into mice• in vitro culture• xenodiagnosis• PCR

• serological tests• hemagglutination• immunofluorescence• ELISA• complement fixation

DIAGNOSIS

Page 30: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative

• acute stage–nifurtimox (8-16 mg/kg/day, 60-90 days)

–benzidazole (5-7 mg/kg/day, 30-120 days)

–allopurinol (experimental)–azole antifungal agents (experimental)

• chronic stage–treat symptoms

TREATMENT

Page 31: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative

Viotta et al (1994) Am. Heart J. 127:151

benznidazole treatment (5 mg/kg/day, 30 d) followed for 8 years

% of patients exhibitingtreated (131) control (70)

electrocardiogramchanges 4% 30%deterioration inclinical condition 2% 17%sero-negativeconversion 19% 6%

Page 32: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative

Lauria-Pires et al (2000) AJTMH 63:111

• Brasília street cleaners treatment• standard treatment with nifurtimox or

benznidazole• 10 year follow up

• treated vs. untreated:• no parasitiological cure (PCR)• no sero-negative conversion• no ECG improvements

• administration of nitroderivatives• severe side effects• compliance problems

Page 33: 16-18 million infected 100 million at risk 50,000 deaths annually leading cause of cardiac disease in S. and Central America Trypanosoma cruzi causative

Trypanosoma rangeli

• can be confused with T. cruzi

• non-pathogenic for humans

• pathogenic for triatomines

mode of transmission?• found in both salivary

glands and feces